AEGR

Aegerion Pharmaceuticals Announces Presentation at the 31st Annual J.P. Morgan Healthcare Conference

[at noodls] – CAMBRIDGE, Mass., Jan. 3, 2013 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc.(Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]

FDA Approves Aegerion Pharmaceuticals’ JUXTAPID(TM) (lomitapide) Capsules for Homozygous Familial Hypercholesterolemia (HoFH)

[at noodls] – CAMBRIDGE, Mass., Dec. 24, 2012 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of novel, life-altering … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]

Aegerion Pharmaceuticals Reserves Shares for Inducement Stock Options

[at noodls] – CAMBRIDGE, Mass., Dec. 6, 2012 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]

Aegerion Pharmaceuticals Announces Issuance of Patent by European Patent Office

[at noodls] – CAMBRIDGE, Mass., Nov. 28, 2012 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboard […]

Aegerion Pharmaceuticals Announces Third Quarter 2012 Financial Results

[at noodls] – CAMBRIDGE, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboard […]

FDA Advisory Committee Recommends Approval of Lomitapide for Treatment of Homozygous Familial Hypercholesterolemia (HoFH)

[at noodls] – CAMBRIDGE, Mass., Oct. 17, 2012 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboard […]

Trading of Common Stock of Aegerion Pharmaceuticals Halted Today

[at noodls] – CAMBRIDGE, Mass., Oct. 17, 2012 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboard […]